Search

Your search keyword '"Dorman P.J."' showing total 14 results
Start Over Author "Dorman P.J."
14 results on '"Dorman P.J."'

2. sj-docx-1-jdr-10.1177_00220345221128226 – Supplemental material for Persistent Orofacial Pain Attendances at General Medical Practitioners

Author

Currie, C.C., Palmer, J., Stone, S.J., Brocklehurst, P., Aggarwal, V.R., Dorman, P.J., Pearce, M.S., and Durham, J.

Subjects
110599 Dentistry not elsewhere classified, FOS: Materials engineering, FOS: Clinical medicine, 91299 Materials Engineering not elsewhere classified
Abstract

Supplemental material, sj-docx-1-jdr-10.1177_00220345221128226 for Persistent Orofacial Pain Attendances at General Medical Practitioners by C.C. Currie, J. Palmer, S.J. Stone, P. Brocklehurst, V.R. Aggarwal, P.J. Dorman, M.S. Pearce and J. Durham in Journal of Dental Research

Published
2022
Full Text
View/download PDF

3. Persistent Orofacial Pain Attendances at General Medical Practitioners.

Author

Currie, C.C., Palmer, J., Stone, S.J., Brocklehurst, P., Aggarwal, V.R., Dorman, P.J., Pearce, M.S., and Durham, J.

Subjects
OROFACIAL pain, TEMPOROMANDIBULAR disorders, FACIAL pain, BURNING mouth syndrome, NEURALGIA, MEDICAL care research
Abstract

Patients with persistent orofacial pain (POFP) can go through complex care pathways to receive a diagnosis and management, which can negatively affect their pain. This study aimed to describe 44-y trends in attendances at Welsh medical practices for POFP and establish the number of attendances per patient and referrals associated with orofacial pain and factors that may predict whether a patient is referred. A retrospective observational study was completed using the nationwide Secure Anonymised Information Linkage Databank of visits to general medical practices in Wales (UK). Data were extracted using diagnostic codes ("Read codes"). Orofacial and migraine Read codes were extracted between 1974 and 2017. Data were analyzed using descriptive statistics and univariate and multivariable logistic regression. Over the 44-y period, there were 468,827 POFP and migraine diagnostic codes, accounting for 468,137 patient attendances, or 301,832 patients. The overall attendance rate was 4.22 attendances per 1,000 patient-years (95% confidence interval [CI], 4.21–4.23). The attendance rate increased over the study period. Almost one-third of patients (n = 92,192, 30.54%) attended more than once over the study period, and 15.83% attended more than once within a 12-mo period. There were 20,103 referral codes that were associated with 8,183 patients, with over half these patients being referred more than once. Odds of receiving a referral were highest in females (odds ratio [OR], 1.23; 95% CI, 1.17–1.29), in those living in rural locations (OR, 1.17; 95% CI, 1.12–1.22), and in the least deprived quintile (OR, 1.39; 95% CI, 1.29–1.48). Odds also increased with increasing age (OR, 1.03; 95% CI, 1.03–1.03). The increasing attendance may be explained by the increasing incidence of POFP within the population. These patients can attend on a repeated basis, and very few are referred, but when they are, this may occur multiple times; therefore, current care pathways could be improved. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

4. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

Author

Rothwell, P.M., McDowell, Z., Wong, C.K., and Dorman, P.J.

Subjects
Multiple sclerosis -- Psychological aspects -- Surveys, Disability evaluation -- Surveys -- Psychological aspects, Quality of life -- Evaluation -- Psychological aspects -- Surveys, Health, Psychological aspects, Evaluation, Surveys
Abstract

Introduction Optimal assessment of the efficacy of a clinical intervention depends on the natural course of the disease under study. Sometimes it may be reasonable simply to measure the effect [...]

Published
1997

5. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial

Author

Bonati, L.H., Dobson, J., Featherstone, R.L., Ederle, J., Worp, H.B. van der, Borst, G.J. de, Mali, W.P., Beard, J.D., Cleveland, T., Engelter, S.T., Lyrer, P.A., Ford, G.A., Dorman, P.J., Brown, M.M., Leeuw, F.E. de, et al., Bonati, L.H., Dobson, J., Featherstone, R.L., Ederle, J., Worp, H.B. van der, Borst, G.J. de, Mali, W.P., Beard, J.D., Cleveland, T., Engelter, S.T., Lyrer, P.A., Ford, G.A., Dorman, P.J., Brown, M.M., Leeuw, F.E. de, and et al.

Abstract

Contains fulltext : 153307.pdf (Publisher’s version ) (Open Access), BACKGROUND: Stenting is an alternative to endarterectomy for treatment of carotid artery stenosis, but long-term efficacy is uncertain. We report long-term data from the randomised International Carotid Stenting Study comparison of these treatments. METHODS: Patients with symptomatic carotid stenosis were randomly assigned 1:1 to open treatment with stenting or endarterectomy at 50 centres worldwide. Randomisation was computer generated centrally and allocated by telephone call or fax. Major outcomes were assessed by an independent endpoint committee unaware of treatment assignment. The primary endpoint was fatal or disabling stroke in any territory after randomisation to the end of follow-up. Analysis was by intention to treat ([ITT] all patients) and per protocol from 31 days after treatment (all patients in whom assigned treatment was completed). Functional ability was rated with the modified Rankin scale. This study is registered, number ISRCTN25337470. FINDINGS: 1713 patients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4.2 years (IQR 3.0-5.2, maximum 10.0). Three patients withdrew immediately and, therefore, the ITT population comprised 1710 patients. The number of fatal or disabling strokes (52 vs 49) and cumulative 5-year risk did not differ significantly between the stenting and endarterectomy groups (6.4% vs 6.5%; hazard ratio [HR] 1.06, 95% CI 0.72-1.57, p=0.77). Any stroke was more frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population, 5-year cumulative risk 15.2% vs 9.4%, HR 1.71, 95% CI 1.28-2.30, p<0.001; per-protocol population, 5-year cumulative risk 8.9% vs 5.8%, 1.53, 1.02-2.31, p=0.04), but were mainly non-disabling strokes. The distribution of modified Rankin scale scores at 1 year, 5 years, or final follow-up did not differ significantly between treatment groups. INTERPRETATION: Long-term functional outcome and risk of fatal or disabling stroke are simila

Published
2015

6. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial.

Author

Ederle, J., Dobson, J., Featherstone, R.L., Bonati, L.H., Worp, H.B. van der, Borst, G.J. de, Lo, T.H., Gaines, P., Dorman, P.J., Macdonald, S., Lyrer, P.A., Hendriks, J.M., McCollum, C., Nederkoorn, P.J., Brown, M.M., Blankensteijn, J.D., Leeuw, F.E. de, Schultze Kool, L.J., Vliet, J.A. van der, et al., Ederle, J., Dobson, J., Featherstone, R.L., Bonati, L.H., Worp, H.B. van der, Borst, G.J. de, Lo, T.H., Gaines, P., Dorman, P.J., Macdonald, S., Lyrer, P.A., Hendriks, J.M., McCollum, C., Nederkoorn, P.J., Brown, M.M., Blankensteijn, J.D., Leeuw, F.E. de, Schultze Kool, L.J., Vliet, J.A. van der, and et al.

Abstract

Contains fulltext : 88112.pdf (publisher's version ) (Closed access), BACKGROUND: Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not established equivalent safety and efficacy. We compared the safety of carotid artery stenting with that of carotid endarterectomy. METHODS: The International Carotid Stenting Study (ICSS) is a multicentre, international, randomised controlled trial with blinded adjudication of outcomes. Patients with recently symptomatic carotid artery stenosis were randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy. Randomisation was by telephone call or fax to a central computerised service and was stratified by centre with minimisation for sex, age, contralateral occlusion, and side of the randomised artery. Patients and investigators were not masked to treatment assignment. Patients were followed up by independent clinicians not directly involved in delivering the randomised treatment. The primary outcome measure of the trial is the 3-year rate of fatal or disabling stroke in any territory, which has not been analysed yet. The main outcome measure for the interim safety analysis was the 120-day rate of stroke, death, or procedural myocardial infarction. Analysis was by intention to treat (ITT). This study is registered, number ISRCTN25337470. FINDINGS: The trial enrolled 1713 patients (stenting group, n=855; endarterectomy group, n=858). Two patients in the stenting group and one in the endarterectomy group withdrew immediately after randomisation, and were not included in the ITT analysis. Between randomisation and 120 days, there were 34 (Kaplan-Meier estimate 4.0%) events of disabling stroke or death in the stenting group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.77-2.11). The incidence of stroke, death, or procedural myocardial infarction was 8.5% in the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2

Published
2010

7. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial.

Author

Giroux M.-F., Prakash K.G., Serracino-Inglott F., Subramanian G., Symth J.V., Walker M.G., Clarke M., Davis M., Dixit S.A., Dorman P., Dyker A., Ford G., Golkar A., Jackson R., Jayakrishnan V., Lambert D., Lees T., Louw S., Mendelow A.D., Rodgers H., Rose J., Stansby G., Wyatt M., Baker T., Baldwin N., Jones L., Mitchell D., Munro E., Thornton M., Baker D., Davis N., Hamilton G., Platts A., Tibballs J., Beard J., Cleveland T., Dodd D., Gaines P., Lonsdale R., Nair R., Nassef A., Nawaz S., Venables G., Belli A., Clifton A., Cloud G., Halliday A., Markus H., McFarland R., Morgan R., Pereira A., Thompson A., Chataway J., Cheshire N., Gibbs R., Hammady M., Jenkins M., Malik I., Wolfe J., Adiseshiah M., Bishop C., Brew S., Brookes J., Jager R., Kitchen N., Ashleigh R., Butterfield S., Gamble G.E., Nasim A., O'Neill P., Wong J., Edwards R.D., Lees K.R., MacKay A.J., Moss J., Rogers P., Ederle J., Dobson J., Featherstone R.L., Bonati L.H., van der Worp H.B., de Borst G.J., Hauw Lo T., Dorman P.J., Macdonald S., Lyrer P.A., McCollum C., Nederkoorn P.J., Brown M.M., Algra A., Bamford J., Bland M., Hacke W., Mas J.L., McGuire A.J., Sidhu P., Bradbury A., Collins R., Molyneux A., Naylor R., Warlow C., Ferro M., Thomas D., Featherstone R.F., Tindall H., McCabe D., Wallis A., Coward L., Brooks M., Chambers B., Chan A., Chu P., Clark D., Dewey H., Donnan G., Fell G., Hoare M., Molan M., Roberts A., Roberts N., Beiles B., Bladin C., Clifford C., Grigg M., New G., Bell R., Bower S., Chong W., Holt M., Saunder A., Than P.G., Gett S., Leggett D., McGahan T., Quinn J., Ray M., Wong A., Woodruff P., Foreman R., Schultz D., Scroop R., Stanley B., Allard B., Atkinson N., Cambell W., Davies S., Field P., Milne P., Mitchell P., Tress B., Yan B., Beasley A., Dunbabin D., Stary D., Walker S., Cras P., d'Archambeau O., Hendriks J.M.H., Van Schil P., Bosiers M., Deloose K., van Buggenhout E., De Letter J., Devos V., Ghekiere J., Vanhooren G., Astarci P., Hammer F., Lacroix V., Verhelst R., DeJaegher L., Peeters A., Verbist J., Blair J.-F., Caron J.L., Daneault N., Guilbert F., Lanthier S., Lebrun L.-H., Oliva V., Raymond J., Roy D., Soulez G., Weill A., Hill M., Hu W., Hudion M., Morrish W., Sutherland G., Alback A., Harno H., Ijas P., Kaste M., Lepantalo M., Mustanoja S., Paananen T., Porras M., Putaala J., Railo M., Sairanen T., Soinne L., Vehmas A., Vikatmaa P., Goertler M., Halloul Z., Skalej M., Brennan P., Kelly C., Leahy A., Moroney J., Thornton J., Koelemay M.J.W., Reekers J.A.A., Roos Y.B.W.E.M., Hendriks J.M., Koudstaal P.J., Pattynama P.M.T., van der Lugt A., van Dijk L.C., van Sambeek M.R.H.M., van Urk H., Verhagen H.J.M., Bruijninckx C.M.A., de Bruijn S.F., Keunen R., Knippenberg B., Mosch A., Treurniet F., van Dijk L., van Overhagen H., Wever J., de Beer F.C., van den Berg J.S.P., van Hasselt B.A.A.M., Zeilstra D.J., Boiten J., de Mol van Otterloo J.C.A., de Vries A.C., Lycklama a Nijeholt G.J., van der Kallen B.F.W., Blankensteijn J.D., De Leeuw F.E., Schultze Kool L.J., van der Vliet J.A., de Kort G.A.P., Kapelle L.J., Lo T.H., Mali W.P.T.M., Moll F., Verhagen H., Barber P.A., Bourchier R., Hill A., Holden A., Stewart J., Bakke S.J., Krohg-Sorensen K., Skjelland M., Tennoe B., Bialek P., Biejat Z., Czepiel W., Czlonkowska A., Dowzenko A., Jedrzejewska J., Kobayashi A., Lelek M., Polanski J., Kirbis J., Milosevic Z., Zvan B., Blasco J., Chamorro A., Macho J., Obach V., Riambau V., San Roman L., Branera J., Canovas D., Estela J., Gimenez Gaibar A., Perendreu J., Bjorses K., Gottsater A., Ivancev K., Maetzsch T., Sonesson B., Berg B., Delle M., Formgren J., Gillgren P., Kall T.-B., Konrad P., Nyman N., Takolander R., Andersson T., Malmstedt J., Soderman M., Wahlgren C., Wahlgren N., Binaghi S., Hirt L., Michel P., Ruchat P., Engelter S.T., Fluri F., Guerke L., Jacob A.L., Kirsch E., Radue E.-W., Stierli P., Wasner M., Wetzel S., Bonvin C., Kalangos A., Lovblad K., Murith N., Ruefenacht D., Sztajzel R., Higgins N., Kirkpatrick P.J., Martin P., Adam D., Bell J., Bradbury A.W., Crowe P., Gannon M., Henderson M.J., Sandler D., Shinton R.A., Scriven J.M., Wilmink T., D'Souza S., Egun A., Guta R., Punekar S., Seriki D.M., Thomson G., Brennan J.A., Enevoldson T.P., Gilling-Smith G., Gould D.A., Harris P.L., McWilliams R.G., Nasser H.-C., White R., Giroux M.-F., Prakash K.G., Serracino-Inglott F., Subramanian G., Symth J.V., Walker M.G., Clarke M., Davis M., Dixit S.A., Dorman P., Dyker A., Ford G., Golkar A., Jackson R., Jayakrishnan V., Lambert D., Lees T., Louw S., Mendelow A.D., Rodgers H., Rose J., Stansby G., Wyatt M., Baker T., Baldwin N., Jones L., Mitchell D., Munro E., Thornton M., Baker D., Davis N., Hamilton G., Platts A., Tibballs J., Beard J., Cleveland T., Dodd D., Gaines P., Lonsdale R., Nair R., Nassef A., Nawaz S., Venables G., Belli A., Clifton A., Cloud G., Halliday A., Markus H., McFarland R., Morgan R., Pereira A., Thompson A., Chataway J., Cheshire N., Gibbs R., Hammady M., Jenkins M., Malik I., Wolfe J., Adiseshiah M., Bishop C., Brew S., Brookes J., Jager R., Kitchen N., Ashleigh R., Butterfield S., Gamble G.E., Nasim A., O'Neill P., Wong J., Edwards R.D., Lees K.R., MacKay A.J., Moss J., Rogers P., Ederle J., Dobson J., Featherstone R.L., Bonati L.H., van der Worp H.B., de Borst G.J., Hauw Lo T., Dorman P.J., Macdonald S., Lyrer P.A., McCollum C., Nederkoorn P.J., Brown M.M., Algra A., Bamford J., Bland M., Hacke W., Mas J.L., McGuire A.J., Sidhu P., Bradbury A., Collins R., Molyneux A., Naylor R., Warlow C., Ferro M., Thomas D., Featherstone R.F., Tindall H., McCabe D., Wallis A., Coward L., Brooks M., Chambers B., Chan A., Chu P., Clark D., Dewey H., Donnan G., Fell G., Hoare M., Molan M., Roberts A., Roberts N., Beiles B., Bladin C., Clifford C., Grigg M., New G., Bell R., Bower S., Chong W., Holt M., Saunder A., Than P.G., Gett S., Leggett D., McGahan T., Quinn J., Ray M., Wong A., Woodruff P., Foreman R., Schultz D., Scroop R., Stanley B., Allard B., Atkinson N., Cambell W., Davies S., Field P., Milne P., Mitchell P., Tress B., Yan B., Beasley A., Dunbabin D., Stary D., Walker S., Cras P., d'Archambeau O., Hendriks J.M.H., Van Schil P., Bosiers M., Deloose K., van Buggenhout E., De Letter J., Devos V., Ghekiere J., Vanhooren G., Astarci P., Hammer F., Lacroix V., Verhelst R., DeJaegher L., Peeters A., Verbist J., Blair J.-F., Caron J.L., Daneault N., Guilbert F., Lanthier S., Lebrun L.-H., Oliva V., Raymond J., Roy D., Soulez G., Weill A., Hill M., Hu W., Hudion M., Morrish W., Sutherland G., Alback A., Harno H., Ijas P., Kaste M., Lepantalo M., Mustanoja S., Paananen T., Porras M., Putaala J., Railo M., Sairanen T., Soinne L., Vehmas A., Vikatmaa P., Goertler M., Halloul Z., Skalej M., Brennan P., Kelly C., Leahy A., Moroney J., Thornton J., Koelemay M.J.W., Reekers J.A.A., Roos Y.B.W.E.M., Hendriks J.M., Koudstaal P.J., Pattynama P.M.T., van der Lugt A., van Dijk L.C., van Sambeek M.R.H.M., van Urk H., Verhagen H.J.M., Bruijninckx C.M.A., de Bruijn S.F., Keunen R., Knippenberg B., Mosch A., Treurniet F., van Dijk L., van Overhagen H., Wever J., de Beer F.C., van den Berg J.S.P., van Hasselt B.A.A.M., Zeilstra D.J., Boiten J., de Mol van Otterloo J.C.A., de Vries A.C., Lycklama a Nijeholt G.J., van der Kallen B.F.W., Blankensteijn J.D., De Leeuw F.E., Schultze Kool L.J., van der Vliet J.A., de Kort G.A.P., Kapelle L.J., Lo T.H., Mali W.P.T.M., Moll F., Verhagen H., Barber P.A., Bourchier R., Hill A., Holden A., Stewart J., Bakke S.J., Krohg-Sorensen K., Skjelland M., Tennoe B., Bialek P., Biejat Z., Czepiel W., Czlonkowska A., Dowzenko A., Jedrzejewska J., Kobayashi A., Lelek M., Polanski J., Kirbis J., Milosevic Z., Zvan B., Blasco J., Chamorro A., Macho J., Obach V., Riambau V., San Roman L., Branera J., Canovas D., Estela J., Gimenez Gaibar A., Perendreu J., Bjorses K., Gottsater A., Ivancev K., Maetzsch T., Sonesson B., Berg B., Delle M., Formgren J., Gillgren P., Kall T.-B., Konrad P., Nyman N., Takolander R., Andersson T., Malmstedt J., Soderman M., Wahlgren C., Wahlgren N., Binaghi S., Hirt L., Michel P., Ruchat P., Engelter S.T., Fluri F., Guerke L., Jacob A.L., Kirsch E., Radue E.-W., Stierli P., Wasner M., Wetzel S., Bonvin C., Kalangos A., Lovblad K., Murith N., Ruefenacht D., Sztajzel R., Higgins N., Kirkpatrick P.J., Martin P., Adam D., Bell J., Bradbury A.W., Crowe P., Gannon M., Henderson M.J., Sandler D., Shinton R.A., Scriven J.M., Wilmink T., D'Souza S., Egun A., Guta R., Punekar S., Seriki D.M., Thomson G., Brennan J.A., Enevoldson T.P., Gilling-Smith G., Gould D.A., Harris P.L., McWilliams R.G., Nasser H.-C., and White R.

Abstract

Background: Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not established equivalent safety and efficacy. We compared the safety of carotid artery stenting with that of carotid endarterectomy. Method(s): The International Carotid Stenting Study (ICSS) is a multicentre, international, randomised controlled trial with blinded adjudication of outcomes. Patients with recently symptomatic carotid artery stenosis were randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy. Randomisation was by telephone call or fax to a central computerised service and was stratified by centre with minimisation for sex, age, contralateral occlusion, and side of the randomised artery. Patients and investigators were not masked to treatment assignment. Patients were followed up by independent clinicians not directly involved in delivering the randomised treatment. The primary outcome measure of the trial is the 3-year rate of fatal or disabling stroke in any territory, which has not been analysed yet. The main outcome measure for the interim safety analysis was the 120-day rate of stroke, death, or procedural myocardial infarction. Analysis was by intention to treat (ITT). This study is registered, number ISRCTN25337470. Finding(s): The trial enrolled 1713 patients (stenting group, n=855; endarterectomy group, n=858). Two patients in the stenting group and one in the endarterectomy group withdrew immediately after randomisation, and were not included in the ITT analysis. Between randomisation and 120 days, there were 34 (Kaplan-Meier estimate 4.0%) events of disabling stroke or death in the stenting group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.77-2.11). The incidence of stroke, death, or procedural myocardial infarction was 8.5% in the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.

Published
2010

8. A study of production in semileptonic B decay

Author

Buskulic, D, primary, Casper, D, additional, De Bonis, I, additional, Decamp, D, additional, Ghez, P, additional, Goy, C, additional, Lees, J.-P, additional, Minard, M.-N, additional, Odier, P, additional, Pietrzyk, B, additional, Ariztizabal, F, additional, Chmeissani, M, additional, Crespo, J.M, additional, Efthymiopoulos, I, additional, Fernandez, E, additional, Fernandez-Bosman, M, additional, Gaitan, V, additional, Garrido, Ll, additional, Martinez, M, additional, Orteu, S, additional, Pacheco, A, additional, Padilla, C, additional, Palla, F, additional, Pascual, A, additional, Perlas, J.A, additional, Sanchez, F, additional, Teubert, F, additional, Creanza, D, additional, de Palma, M, additional, Farilla, A, additional, Iaselli, G, additional, Maggi, G, additional, Marinelli, N, additional, Natali, S, additional, Nuzzo, S, additional, Ranieri, A, additional, Raso, G, additional, Romano, F, additional, Ruggieri, F, additional, Selvaggi, G, additional, Silvestris, L, additional, Tempesta, P, additional, Zito, G, additional, Huang, X, additional, Lin, J, additional, Ouyang, Q, additional, Wang, T, additional, Xie, Y, additional, Xu, R, additional, Xue, S, additional, Zhang, J, additional, Zhang, L, additional, Zhao, W, additional, Bonvicini, G, additional, Cattaneo, M, additional, Comas, P, additional, Coyle, P, additional, Drevermann, H, additional, Engelhardt, A, additional, Forty, R.W, additional, Frank, M, additional, Ganis, G, additional, Girone, M, additional, Hagelberg, R, additional, Harvey, J, additional, Jacobsen, R, additional, Jost, B, additional, Knobloch, J, additional, Lehraus, I, additional, Maggi, M, additional, Markou, C, additional, Martin, E.B, additional, Mato, P, additional, Meinhard, H, additional, Minten, A, additional, Miquel, R, additional, Palazzi, P, additional, Pater, J.R, additional, Perrodo, P, additional, Pusztaszeri, J.-F, additional, Ranjard, F, additional, Rolandi, L, additional, Schlatter, D, additional, Schmelling, M, additional, Tejessy, W, additional, Tomalin, I.R, additional, Veenhof, R, additional, Venturi, A, additional, Wachsmuth, H, additional, Wiedenmann, W, additional, Wildish, T, additional, Witzeling, W, additional, Wotschack, J, additional, Ajaltouni, Z, additional, Bardadin-Otwinowska, M, additional, Barres, A, additional, Boyer, C, additional, Falvard, A, additional, Gay, P, additional, Guicheney, C, additional, Henrard, P, additional, Jousset, J, additional, Michel, B, additional, Monteil, S, additional, Montret, J-C, additional, Pallin, D, additional, Perret, P, additional, Podlyski, F, additional, Proriol, J, additional, Rossignol, J.-M, additional, Saadi, F, additional, Fearnley, T, additional, Hansen, J.B, additional, Hansen, J.D, additional, Hansen, J.R, additional, Hansen, P.H, additional, Johnson, S.D, additional, Nilsson, B.S, additional, Kyriakis, A, additional, Simopoulou, E, additional, Siotis, I, additional, Vayaki, A, additional, Zachariadou, K, additional, Blondel, A, additional, Bonneaud, G, additional, Brient, J.C, additional, Bourdon, P, additional, Passalacqua, L, additional, Rougé, A, additional, Rumpf, M, additional, Tanaka, R, additional, Valassi, A, additional, Verderi, M, additional, Videau, H, additional, Candlin, D.J, additional, Parsons, M.I, additional, Veitch, E, additional, Focardi, E, additional, Parrini, G, additional, Corden, M, additional, Delfino, M, additional, Georgiopoulos, C, additional, Jaffe, D.E, additional, Antonelli, A, additional, Bencivenni, G, additional, Bologna, G, additional, Bossi, F, additional, Campana, P, additional, Capon, G, additional, Cerutti, F, additional, Chiarella, V, additional, Felici, G, additional, Laurelli, P, additional, Mannocchi, G, additional, Murtas, F, additional, Murtas, G.P, additional, Pepe-Altarelli, M, additional, Salomone, S, additional, Colrain, P, additional, ten Have, I, additional, Knowles, I.G, additional, Lynch, J.G, additional, Maitland, W, additional, Morton, W.T, additional, Raine, C, additional, Reeves, P, additional, Scarr, J.M, additional, Smith, K, additional, Smith, M.G, additional, Thompson, A.S, additional, Thorn, S, additional, Turnbull, R.M, additional, Becker, U, additional, Braun, O, additional, Geweniger, C, additional, Graefe, G, additional, Hanke, P, additional, Hepp, V, additional, Kluge, E.E, additional, Putzer, A, additional, Rensch, B, additional, Schmidt, M, additional, Sommer, J, additional, Stenzel, H, additional, Tittel, K, additional, Wunsch, M, additional, Beuselinck, R, additional, Binnie, D.M, additional, Cameron, W, additional, Colling, D.J, additional, Dorman, P.J, additional, Konstantinidis, N, additional, Moneta, L, additional, Moutoussi, A, additional, Nash, J, additional, San Martin, G, additional, Sedgbeer, J.K, additional, Stacey, A.M, additional, Dissertori, G, additional, Girtler, P, additional, Kneringer, E, additional, Kuhn, D, additional, Rudolph, G, additional, Bowdery, C.K, additional, Brodbeck, T.J, additional, Finch, A.J, additional, Foster, F, additional, Hughes, G, additional, Jackson, D, additional, Keemer, N.R, additional, Nuttall, M, additional, Patel, A, additional, Sloan, T, additional, Snow, S.W, additional, Whelan, E.P, additional, Galla, A, additional, Greene, A.M, additional, Kleinknecht, K, additional, Raab, J, additional, Renk, B, additional, Sander, H.-G, additional, Schmidt, H, additional, Walther, S.M, additional, Wanke, R, additional, Wolf, B, additional, Aubert, J.J, additional, Bencheikh, A.M, additional, Benchouk, C, additional, Bonissent, A, additional, Bujosa, G, additional, Calvet, D, additional, Carr, J, additional, Diaconu, C, additional, Etienne, F, additional, Thulasidas, M, additional, Nicod, D, additional, Payre, P, additional, Rousseau, D, additional, Talby, M, additional, Abt, I, additional, Assmann, R, additional, Bauer, C, additional, Blum, W, additional, Brown, D, additional, Dietl, H, additional, Dydak, F, additional, Gotzhein, C, additional, Halley, A.W, additional, Jakobs, K, additional, Kroha, H, additional, Lütjens, G, additional, Lutz, G, additional, Männer, W, additional, Moser, H.-G, additional, Richter, R, additional, Rosado-Schlosser, A, additional, Schwarz, A.S, additional, Settles, R, additional, Seywerd, H, additional, Stierlin, U, additional, Denis, R.St, additional, Wolf, G, additional, Alemany, R, additional, Boucrot, J, additional, Callot, O, additional, Cordier, A, additional, Courault, F, additional, Davier, M, additional, Duflot, L, additional, Grivaz, J.-F, additional, Heusse, Ph, additional, Jacquet, M, additional, Janot, P, additional, Kim, D.W, additional, Le Diberder, F, additional, Lefrançois, J, additional, Lutz, A.-M, additional, Musolino, G, additional, Nikolic, I, additional, Park, H.J, additional, Park, I.C, additional, Schune, M.-H, additional, Simion, S, additional, Veillet, J.-J, additional, Videau, I, additional, Abbaneo, D, additional, Bagliesi, G, additional, Batignani, G, additional, Bettarini, S, additional, Bottigli, U, additional, Bozzi, C, additional, Calderini, G, additional, Carpinelli, M, additional, Ciocci, M.A, additional, Ciulli, V, additional, Dell'Orso, R, additional, Ferrante, I, additional, Fidecaro, F, additional, Foà, L, additional, Forti, F, additional, Giassi, A, additional, Giorgi, M.A, additional, Gregorio, A, additional, Ligabue, F, additional, Lusiani, A, additional, Marrocchesi, P.S, additional, Messineo, A, additional, Rizzo, G, additional, Sanguinetti, G, additional, Sciabà, A, additional, Spagnolo, P, additional, Steinberger, J, additional, Tenchini, R, additional, Tonelli, G, additional, Triggiani, G, additional, Vannini, C, additional, Verdini, P.G, additional, Walsh, J, additional, Betteridge, A.P, additional, Blair, G.A, additional, Bryant, L.M, additional, Gao, Y, additional, Green, M.G, additional, Johnson, D.L, additional, Medcalf, T, additional, Mir, Ll.M, additional, Strong, J.A, additional, Bertin, V, additional, Botterill, D.R, additional, Clifft, R.W, additional, Edgecock, T.R, additional, Haywood, S, additional, Edwards, M, additional, Maley, P, additional, Norton, P.R, additional, Thompson, J.C, additional, Bloch-Devaux, B, additional, Colas, P, additional, Duarte, H, additional, Emery, S, additional, Kozanecki, W, additional, Lançon, E, additional, Lemaire, M.C, additional, Locci, E, additional, Marx, B, additional, Perez, P, additional, Rander, J, additional, Renardy, J.-F, additional, Rosowsky, A, additional, Roussarie, A, additional, Schuller, J.-P, additional, Schwindling, J, additional, Si Mohand, D, additional, Trabelsi, A, additional, Vallage, B, additional, Johnson, R.P, additional, Litke, A.M, additional, Taylor, G, additional, Wear, J, additional, Beddall, A, additional, Booth, C.N, additional, Boswell, R, additional, Cartwright, S, additional, Combley, F, additional, Dawson, I, additional, Koksal, A, additional, Letho, M, additional, Newton, W.M, additional, Rankin, C, additional, Thompson, L.F, additional, Böhrer, A, additional, Brandt, S, additional, Cowan, G, additional, Feigl, E, additional, Grupen, C, additional, Lutters, G, additional, Minguet-Rodriguez, J, additional, Rivera, F, additional, Saraiva, P, additional, Schäfer, U, additional, Smolik, L, additional, Bosisio, L, additional, Della Marina, R, additional, Giannini, G, additional, Gobbo, B, additional, Pitis, L, additional, Ragusa, F, additional, Kim, H, additional, Rothberg, J, additional, Wasserbaech, S, additional, Armstrong, S.R, additional, Bellantoni, L, additional, Elmer, P, additional, Feng, Z, additional, Ferguson, D.P.S, additional, Gao, Y.S, additional, González, S, additional, Grahl, J, additional, Harton, J.L, additional, Hayes, O.J, additional, Hu, H, additional, McNamara, P.A, additional, Nachtman, J.M, additional, Orejudos, W, additional, Pan, Y.B, additional, Saadi, Y, additional, Schmitt, M, additional, Scott, I.J, additional, Sharma, V, additional, Turk, J.D, additional, Walsh, A.M, additional, Weber, F.V, additional, Wu, Sau Lan, additional, Wu, X, additional, Yamartino, J.M, additional, Zheng, M, additional, and Zobernig, G, additional

Published
1995
Full Text
View/download PDF

9. Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke?

Author

Dorman, P.J., Dennis, M., and Sandercock, P.

Abstract

ObjectivesTwo "simple questions" were developed as a minimalist measurement tool to assess outcome in large trials and epidemiological studies after stroke. A previous study of their validity had disclosed ambiguities in their wording. In this study, the clarity, validity, and reliability of a modified version of these simple questions were examined. The relation between patients' responses to these questions and two widely used generic measures of health related quality of life were also studied.MethodsA hospital based stroke register cohort of 152 patients, who were all visited at home by a study nurse, was used to study validity. A cohort of 1753 patients derived from the International Stroke Trial was used to study the relation with measures of quality of life. The sensitivity, specificity, and accuracy with which responses to each question predicted the patients' outcome measured using standard instruments was assessed. The distribution of scores for the EuroQol and SF-36 was examined for patients classified as dependent, independent, and fully recovered by the combined use of the modified simple questions.ResultsThe modified "dependency" question had excellent sensitivity (>85%), specificity (>79%), and accuracy (>82%) for identifying dependency after stroke. The "problems" question had good sensitivity (65-88%) and moderate specificity (36-72%) for the detection of problems in a broad range of domains. The combined use of the modified dependency and problems questions provided a valid, simple, and reliable overall indicator of health related quality of life after stroke.ConclusionsThe modified simple questions have excellent face validity and good measurement properties for the assessment of outcome after stroke. They are particularly well suited for large epidemiological studies and randomised trials.

Published
2000

11. A study of the reaction with the Veneziano model

Author

Bartsch, J., primary, Deutschmann, M., additional, Honecker, R., additional, Schulte, R., additional, Steinberg, R., additional, Böttcher, H., additional, Gensch, U., additional, Nowak, S., additional, Schiller, H., additional, Angelopoulos, A., additional, Cocconi, V.T., additional, Dalpiaz, P.F., additional, Hansen, J.D., additional, Kittel, W., additional, Morrison, D.R.O., additional, Paler, K., additional, Schreiber, H.J., additional, Töfte, H., additional, Dorman, P.J., additional, Goldsack, S.J., additional, Losty, M.J., additional, Mermikides, M.E., additional, Fröhlich, A., additional, Markytan, M., additional, Otter, G., additional, Schmid, P., additional, and Wahl, H., additional

Published
1970
Full Text
View/download PDF

12. Parkinsonism associated with obstructive hydrocephalus due to idiopathic aqueductal stenosis

Author

Zeidler, M., Bateman, D.E., Dorman, P.J., and Ferguson, I.T.

Abstract

Two cases of parkinsonism after recurrent obstructive hydrocephalus due to idiopathic aqueductal stenosis are reported. In both patients an extrapyramidal syndrome was noted in the absence of contemporaneous evidence of hydrocephalus or shunt failure. One of the patients underwent a shunt operation, but showed no clinical improvement. However, both patients improved after the administration of dopaminergic therapy. The seven previously reported cases of this syndrome were reviewed and it is concluded that the prognosis of the parkinsonism is good, usually with total, or near total, resolution. It is recommended that if a patient with idiopathic aqueduct stenosis develops hydrocephalus or evidence of shunt malfunction in association with acute parkinsonism their shunt should be replaced. If there is no evidence of hydrocephalus or shunt malfunction they should initially be treated with domaminergic medication.

Published
1998

Catalog

Books, media, physical & digital resources
See catalog results